DO TUBE SPACERS IMPROVE DRUG DELIVERY IN ASTHMATIC CHILDREN?

InPharma ◽  
1983 ◽  
Vol 394 (1) ◽  
pp. 9-9
2016 ◽  
Vol 17 (15) ◽  
pp. 1773-1798 ◽  
Author(s):  
Abhirup Mandal ◽  
Mitesh Patel ◽  
Ye Sheng ◽  
Ashim K. Mitra

2021 ◽  
Vol 127 (5) ◽  
Author(s):  
Chetan Chavan ◽  
Saniya Prabhune ◽  
Siddhi Shedge ◽  
Rajashree Patwardhan ◽  
Sagar Kamble ◽  
...  

2018 ◽  
Vol 20 (suppl_6) ◽  
pp. vi278-vi278
Author(s):  
Duhyeong Hwang ◽  
Chaemin Lim ◽  
Yuling Zhao ◽  
Hedi Liu ◽  
Alexander V Kabanov ◽  
...  

2020 ◽  
Vol 6 (4) ◽  
pp. 461-470
Author(s):  
Dominic C. Grimberg ◽  
Ankeet Shah ◽  
Wei Phin Tan ◽  
Wiguins Etienne ◽  
Ivan Spasojevic ◽  
...  

BACKGROUND: Nearly 70% of all new cases of bladder cancer are non-muscle invasive disease, the treatment for which includes transurethral resection followed by intravesical therapy. Unfortunately, recurrence rates approach 50% in part due to poor intravesical drug delivery. Hyperthermia is frequently used as an adjunct to intravesical chemotherapy to improve drug delivery and response to treatment. OBJECTIVE: To assess the solubility profile of intravesical chemotherapies under varying conditions of pH and temperature. METHODS: Using microplate laser nephelometry we measured the solubility of three intravesical chemotherapy agents (mitomycin C, gemcitabine, and cisplatin) at varying physical conditions. Drugs were assessed at room temperature (23°C), body temperature (37°C), and 43°C, the temperature used for hyperthermic intravesical treatments. To account for variations in urine pH, solubility was also investigated at pH 4.00, 6.00, and 8.00. RESULTS: Heat incrementally increased the solubility of all three drugs studied. Conversely, pH largely did not impact solubility aside for gemcitabine which showed slightly reduced solubility at pH 8.00 versus 6.00 or 4.00. Mitomycin C at the commonly used 2.0 mg/mL was insoluble at room temperature, but soluble at both 37 and 43°C. CONCLUSIONS: Hyperthermia as an adjunct to intravesical treatment would improve drug solubility, and likely drug delivery as some current regimens are insoluble without heat. Improvements in solubility also allow for testing of alternative administration regimens to improve drug delivery or tolerability. Further studies are needed to confirm that improvements in solubility result in increased drug delivery.


Nano Letters ◽  
2013 ◽  
Vol 13 (6) ◽  
pp. 2528-2534 ◽  
Author(s):  
Tuo Wei ◽  
Juan Liu ◽  
Huili Ma ◽  
Qiang Cheng ◽  
Yuanyu Huang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document